United Therapeutics CEO Sells 9,500 Shares Following Option Exercise; Company Advances $2B Buyback and Positive Trial News
Martine Rothblatt, chairperson and CEO of United Therapeutics (UTHR), sold 9,500 shares on March 23, 2026, after exercising options. The transactions, completed under a 10b5-1 trading plan, generated roughly $5 million. The moves occur alongside a $2 billion share repurchase program, analyst price-target actions, and published positive phase 3 data…